nodes	percent_of_prediction	percent_of_DWPC	metapath
Eprosartan—ABCC2—Carboplatin—testicular cancer	0.138	0.178	CbGbCtD
Eprosartan—ABCC2—Vinblastine—testicular cancer	0.128	0.166	CbGbCtD
Eprosartan—ABCC2—Cisplatin—testicular cancer	0.118	0.152	CbGbCtD
Eprosartan—ABCC2—Etoposide—testicular cancer	0.116	0.149	CbGbCtD
Eprosartan—CYP2C9—Ifosfamide—testicular cancer	0.0813	0.105	CbGbCtD
Eprosartan—ABCC2—Doxorubicin—testicular cancer	0.0789	0.102	CbGbCtD
Eprosartan—ABCC2—Methotrexate—testicular cancer	0.0764	0.0985	CbGbCtD
Eprosartan—CYP2C9—Cisplatin—testicular cancer	0.0396	0.051	CbGbCtD
Eprosartan—Asthenia—Dactinomycin—testicular cancer	0.000312	0.00139	CcSEcCtD
Eprosartan—Blood creatinine increased—Doxorubicin—testicular cancer	0.000311	0.00139	CcSEcCtD
Eprosartan—Asthma—Epirubicin—testicular cancer	0.00031	0.00138	CcSEcCtD
Eprosartan—Paraesthesia—Cisplatin—testicular cancer	0.000308	0.00137	CcSEcCtD
Eprosartan—Thrombocytopenia—Etoposide—testicular cancer	0.000308	0.00137	CcSEcCtD
Eprosartan—Upper respiratory tract infection—Methotrexate—testicular cancer	0.000308	0.00137	CcSEcCtD
Eprosartan—Tachycardia—Etoposide—testicular cancer	0.000307	0.00137	CcSEcCtD
Eprosartan—Dyspnoea—Cisplatin—testicular cancer	0.000306	0.00136	CcSEcCtD
Eprosartan—Hyperhidrosis—Etoposide—testicular cancer	0.000304	0.00136	CcSEcCtD
Eprosartan—Orthostatic hypotension—Doxorubicin—testicular cancer	0.000303	0.00135	CcSEcCtD
Eprosartan—Hypokalaemia—Doxorubicin—testicular cancer	0.000302	0.00135	CcSEcCtD
Eprosartan—Angina pectoris—Epirubicin—testicular cancer	0.000302	0.00135	CcSEcCtD
Eprosartan—Anorexia—Etoposide—testicular cancer	0.0003	0.00134	CcSEcCtD
Eprosartan—Aspartate aminotransferase increased—Doxorubicin—testicular cancer	0.000299	0.00133	CcSEcCtD
Eprosartan—Decreased appetite—Cisplatin—testicular cancer	0.000298	0.00133	CcSEcCtD
Eprosartan—Bronchitis—Epirubicin—testicular cancer	0.000298	0.00133	CcSEcCtD
Eprosartan—Diarrhoea—Dactinomycin—testicular cancer	0.000297	0.00133	CcSEcCtD
Eprosartan—Vomiting—Bleomycin—testicular cancer	0.000296	0.00132	CcSEcCtD
Eprosartan—Depression—Methotrexate—testicular cancer	0.000294	0.00131	CcSEcCtD
Eprosartan—Hypotension—Etoposide—testicular cancer	0.000294	0.00131	CcSEcCtD
Eprosartan—Rash—Bleomycin—testicular cancer	0.000294	0.00131	CcSEcCtD
Eprosartan—Gastritis—Doxorubicin—testicular cancer	0.000293	0.00131	CcSEcCtD
Eprosartan—Pain—Cisplatin—testicular cancer	0.000293	0.00131	CcSEcCtD
Eprosartan—Dermatitis—Bleomycin—testicular cancer	0.000293	0.00131	CcSEcCtD
Eprosartan—Hypersensitivity—Ifosfamide—testicular cancer	0.000293	0.00131	CcSEcCtD
Eprosartan—Alanine aminotransferase increased—Doxorubicin—testicular cancer	0.000292	0.00131	CcSEcCtD
Eprosartan—Muscular weakness—Doxorubicin—testicular cancer	0.000292	0.00131	CcSEcCtD
Eprosartan—Renal failure—Methotrexate—testicular cancer	0.00029	0.00129	CcSEcCtD
Eprosartan—Upper respiratory tract infection—Epirubicin—testicular cancer	0.000288	0.00128	CcSEcCtD
Eprosartan—Conjunctivitis—Methotrexate—testicular cancer	0.000287	0.00128	CcSEcCtD
Eprosartan—Asthma—Doxorubicin—testicular cancer	0.000287	0.00128	CcSEcCtD
Eprosartan—Pollakiuria—Epirubicin—testicular cancer	0.000286	0.00128	CcSEcCtD
Eprosartan—Asthenia—Ifosfamide—testicular cancer	0.000285	0.00127	CcSEcCtD
Eprosartan—Feeling abnormal—Cisplatin—testicular cancer	0.000283	0.00126	CcSEcCtD
Eprosartan—Paraesthesia—Etoposide—testicular cancer	0.000282	0.00126	CcSEcCtD
Eprosartan—Pruritus—Ifosfamide—testicular cancer	0.000282	0.00126	CcSEcCtD
Eprosartan—Haematuria—Methotrexate—testicular cancer	0.000281	0.00126	CcSEcCtD
Eprosartan—Dyspnoea—Etoposide—testicular cancer	0.00028	0.00125	CcSEcCtD
Eprosartan—Hyperglycaemia—Epirubicin—testicular cancer	0.000279	0.00125	CcSEcCtD
Eprosartan—Somnolence—Etoposide—testicular cancer	0.000279	0.00125	CcSEcCtD
Eprosartan—Angina pectoris—Doxorubicin—testicular cancer	0.000279	0.00125	CcSEcCtD
Eprosartan—Epistaxis—Methotrexate—testicular cancer	0.000278	0.00124	CcSEcCtD
Eprosartan—Nausea—Bleomycin—testicular cancer	0.000277	0.00123	CcSEcCtD
Eprosartan—Vomiting—Dactinomycin—testicular cancer	0.000276	0.00123	CcSEcCtD
Eprosartan—Bronchitis—Doxorubicin—testicular cancer	0.000276	0.00123	CcSEcCtD
Eprosartan—Rash—Dactinomycin—testicular cancer	0.000274	0.00122	CcSEcCtD
Eprosartan—Decreased appetite—Etoposide—testicular cancer	0.000273	0.00122	CcSEcCtD
Eprosartan—Diarrhoea—Ifosfamide—testicular cancer	0.000272	0.00121	CcSEcCtD
Eprosartan—Renal failure—Epirubicin—testicular cancer	0.000271	0.00121	CcSEcCtD
Eprosartan—Body temperature increased—Cisplatin—testicular cancer	0.000271	0.00121	CcSEcCtD
Eprosartan—Fatigue—Etoposide—testicular cancer	0.000271	0.00121	CcSEcCtD
Eprosartan—Neuropathy peripheral—Epirubicin—testicular cancer	0.000271	0.00121	CcSEcCtD
Eprosartan—Constipation—Etoposide—testicular cancer	0.000269	0.0012	CcSEcCtD
Eprosartan—Pain—Etoposide—testicular cancer	0.000269	0.0012	CcSEcCtD
Eprosartan—Conjunctivitis—Epirubicin—testicular cancer	0.000268	0.0012	CcSEcCtD
Eprosartan—Urinary tract infection—Epirubicin—testicular cancer	0.000268	0.0012	CcSEcCtD
Eprosartan—Upper respiratory tract infection—Doxorubicin—testicular cancer	0.000266	0.00119	CcSEcCtD
Eprosartan—Pollakiuria—Doxorubicin—testicular cancer	0.000265	0.00118	CcSEcCtD
Eprosartan—Haematuria—Epirubicin—testicular cancer	0.000263	0.00118	CcSEcCtD
Eprosartan—Dizziness—Ifosfamide—testicular cancer	0.000263	0.00117	CcSEcCtD
Eprosartan—Pharyngitis—Methotrexate—testicular cancer	0.000263	0.00117	CcSEcCtD
Eprosartan—Epistaxis—Epirubicin—testicular cancer	0.000261	0.00116	CcSEcCtD
Eprosartan—Sinusitis—Epirubicin—testicular cancer	0.000259	0.00116	CcSEcCtD
Eprosartan—Feeling abnormal—Etoposide—testicular cancer	0.000259	0.00116	CcSEcCtD
Eprosartan—Hyperglycaemia—Doxorubicin—testicular cancer	0.000259	0.00115	CcSEcCtD
Eprosartan—Nausea—Dactinomycin—testicular cancer	0.000258	0.00115	CcSEcCtD
Eprosartan—Gastrointestinal pain—Etoposide—testicular cancer	0.000257	0.00115	CcSEcCtD
Eprosartan—Visual impairment—Methotrexate—testicular cancer	0.000255	0.00114	CcSEcCtD
Eprosartan—Vomiting—Ifosfamide—testicular cancer	0.000253	0.00113	CcSEcCtD
Eprosartan—Hypersensitivity—Cisplatin—testicular cancer	0.000253	0.00113	CcSEcCtD
Eprosartan—Bradycardia—Epirubicin—testicular cancer	0.000252	0.00113	CcSEcCtD
Eprosartan—Renal failure—Doxorubicin—testicular cancer	0.000251	0.00112	CcSEcCtD
Eprosartan—Rash—Ifosfamide—testicular cancer	0.000251	0.00112	CcSEcCtD
Eprosartan—Dermatitis—Ifosfamide—testicular cancer	0.000251	0.00112	CcSEcCtD
Eprosartan—Neuropathy peripheral—Doxorubicin—testicular cancer	0.000251	0.00112	CcSEcCtD
Eprosartan—Urticaria—Etoposide—testicular cancer	0.00025	0.00111	CcSEcCtD
Eprosartan—Rhinitis—Epirubicin—testicular cancer	0.000249	0.00111	CcSEcCtD
Eprosartan—Abdominal pain—Etoposide—testicular cancer	0.000248	0.00111	CcSEcCtD
Eprosartan—Body temperature increased—Etoposide—testicular cancer	0.000248	0.00111	CcSEcCtD
Eprosartan—Urinary tract infection—Doxorubicin—testicular cancer	0.000248	0.00111	CcSEcCtD
Eprosartan—Conjunctivitis—Doxorubicin—testicular cancer	0.000248	0.00111	CcSEcCtD
Eprosartan—Tinnitus—Methotrexate—testicular cancer	0.000247	0.0011	CcSEcCtD
Eprosartan—Asthenia—Cisplatin—testicular cancer	0.000246	0.0011	CcSEcCtD
Eprosartan—Pharyngitis—Epirubicin—testicular cancer	0.000246	0.0011	CcSEcCtD
Eprosartan—Oedema peripheral—Epirubicin—testicular cancer	0.000244	0.00109	CcSEcCtD
Eprosartan—Haematuria—Doxorubicin—testicular cancer	0.000244	0.00109	CcSEcCtD
Eprosartan—Epistaxis—Doxorubicin—testicular cancer	0.000241	0.00108	CcSEcCtD
Eprosartan—Sinusitis—Doxorubicin—testicular cancer	0.00024	0.00107	CcSEcCtD
Eprosartan—Visual impairment—Epirubicin—testicular cancer	0.000239	0.00107	CcSEcCtD
Eprosartan—Chills—Methotrexate—testicular cancer	0.000238	0.00106	CcSEcCtD
Eprosartan—Nausea—Ifosfamide—testicular cancer	0.000236	0.00105	CcSEcCtD
Eprosartan—Diarrhoea—Cisplatin—testicular cancer	0.000235	0.00105	CcSEcCtD
Eprosartan—Bradycardia—Doxorubicin—testicular cancer	0.000234	0.00104	CcSEcCtD
Eprosartan—Hypersensitivity—Etoposide—testicular cancer	0.000232	0.00103	CcSEcCtD
Eprosartan—Tinnitus—Epirubicin—testicular cancer	0.000231	0.00103	CcSEcCtD
Eprosartan—Rhinitis—Doxorubicin—testicular cancer	0.00023	0.00103	CcSEcCtD
Eprosartan—Pharyngitis—Doxorubicin—testicular cancer	0.000228	0.00102	CcSEcCtD
Eprosartan—Oedema peripheral—Doxorubicin—testicular cancer	0.000226	0.00101	CcSEcCtD
Eprosartan—Asthenia—Etoposide—testicular cancer	0.000225	0.00101	CcSEcCtD
Eprosartan—Back pain—Methotrexate—testicular cancer	0.000223	0.000995	CcSEcCtD
Eprosartan—Chills—Epirubicin—testicular cancer	0.000222	0.000993	CcSEcCtD
Eprosartan—Pruritus—Etoposide—testicular cancer	0.000222	0.000992	CcSEcCtD
Eprosartan—Visual impairment—Doxorubicin—testicular cancer	0.000221	0.000987	CcSEcCtD
Eprosartan—Vomiting—Cisplatin—testicular cancer	0.000218	0.000973	CcSEcCtD
Eprosartan—Rash—Cisplatin—testicular cancer	0.000216	0.000965	CcSEcCtD
Eprosartan—Dermatitis—Cisplatin—testicular cancer	0.000216	0.000964	CcSEcCtD
Eprosartan—Diarrhoea—Etoposide—testicular cancer	0.000215	0.000959	CcSEcCtD
Eprosartan—Ill-defined disorder—Methotrexate—testicular cancer	0.000214	0.000955	CcSEcCtD
Eprosartan—Tinnitus—Doxorubicin—testicular cancer	0.000214	0.000954	CcSEcCtD
Eprosartan—Flatulence—Epirubicin—testicular cancer	0.000213	0.000949	CcSEcCtD
Eprosartan—Tension—Epirubicin—testicular cancer	0.000212	0.000945	CcSEcCtD
Eprosartan—Nervousness—Epirubicin—testicular cancer	0.00021	0.000935	CcSEcCtD
Eprosartan—Back pain—Epirubicin—testicular cancer	0.000209	0.000932	CcSEcCtD
Eprosartan—Malaise—Methotrexate—testicular cancer	0.000208	0.000928	CcSEcCtD
Eprosartan—Dizziness—Etoposide—testicular cancer	0.000208	0.000927	CcSEcCtD
Eprosartan—Muscle spasms—Epirubicin—testicular cancer	0.000208	0.000926	CcSEcCtD
Eprosartan—Vertigo—Methotrexate—testicular cancer	0.000207	0.000925	CcSEcCtD
Eprosartan—Chills—Doxorubicin—testicular cancer	0.000206	0.000919	CcSEcCtD
Eprosartan—Nausea—Cisplatin—testicular cancer	0.000204	0.000909	CcSEcCtD
Eprosartan—Cough—Methotrexate—testicular cancer	0.000201	0.000898	CcSEcCtD
Eprosartan—Ill-defined disorder—Epirubicin—testicular cancer	0.0002	0.000894	CcSEcCtD
Eprosartan—Vomiting—Etoposide—testicular cancer	0.0002	0.000892	CcSEcCtD
Eprosartan—Rash—Etoposide—testicular cancer	0.000198	0.000884	CcSEcCtD
Eprosartan—Dermatitis—Etoposide—testicular cancer	0.000198	0.000883	CcSEcCtD
Eprosartan—Headache—Etoposide—testicular cancer	0.000197	0.000878	CcSEcCtD
Eprosartan—Flatulence—Doxorubicin—testicular cancer	0.000197	0.000878	CcSEcCtD
Eprosartan—Chest pain—Methotrexate—testicular cancer	0.000196	0.000876	CcSEcCtD
Eprosartan—Myalgia—Methotrexate—testicular cancer	0.000196	0.000876	CcSEcCtD
Eprosartan—Arthralgia—Methotrexate—testicular cancer	0.000196	0.000876	CcSEcCtD
Eprosartan—Tension—Doxorubicin—testicular cancer	0.000196	0.000874	CcSEcCtD
Eprosartan—Malaise—Epirubicin—testicular cancer	0.000195	0.000869	CcSEcCtD
Eprosartan—Discomfort—Methotrexate—testicular cancer	0.000194	0.000866	CcSEcCtD
Eprosartan—Nervousness—Doxorubicin—testicular cancer	0.000194	0.000866	CcSEcCtD
Eprosartan—Vertigo—Epirubicin—testicular cancer	0.000194	0.000865	CcSEcCtD
Eprosartan—Syncope—Epirubicin—testicular cancer	0.000194	0.000864	CcSEcCtD
Eprosartan—Back pain—Doxorubicin—testicular cancer	0.000193	0.000862	CcSEcCtD
Eprosartan—Muscle spasms—Doxorubicin—testicular cancer	0.000192	0.000857	CcSEcCtD
Eprosartan—Palpitations—Epirubicin—testicular cancer	0.000191	0.000851	CcSEcCtD
Eprosartan—Loss of consciousness—Epirubicin—testicular cancer	0.00019	0.000846	CcSEcCtD
Eprosartan—Cough—Epirubicin—testicular cancer	0.000188	0.00084	CcSEcCtD
Eprosartan—Nausea—Etoposide—testicular cancer	0.000187	0.000833	CcSEcCtD
Eprosartan—Ill-defined disorder—Doxorubicin—testicular cancer	0.000185	0.000827	CcSEcCtD
Eprosartan—Thrombocytopenia—Methotrexate—testicular cancer	0.000184	0.000822	CcSEcCtD
Eprosartan—Arthralgia—Epirubicin—testicular cancer	0.000184	0.00082	CcSEcCtD
Eprosartan—Chest pain—Epirubicin—testicular cancer	0.000184	0.00082	CcSEcCtD
Eprosartan—Myalgia—Epirubicin—testicular cancer	0.000184	0.00082	CcSEcCtD
Eprosartan—Anxiety—Epirubicin—testicular cancer	0.000183	0.000817	CcSEcCtD
Eprosartan—Hyperhidrosis—Methotrexate—testicular cancer	0.000182	0.000812	CcSEcCtD
Eprosartan—Discomfort—Epirubicin—testicular cancer	0.000182	0.00081	CcSEcCtD
Eprosartan—Malaise—Doxorubicin—testicular cancer	0.00018	0.000804	CcSEcCtD
Eprosartan—Dry mouth—Epirubicin—testicular cancer	0.00018	0.000802	CcSEcCtD
Eprosartan—Vertigo—Doxorubicin—testicular cancer	0.000179	0.000801	CcSEcCtD
Eprosartan—Anorexia—Methotrexate—testicular cancer	0.000179	0.000801	CcSEcCtD
Eprosartan—Syncope—Doxorubicin—testicular cancer	0.000179	0.000799	CcSEcCtD
Eprosartan—Palpitations—Doxorubicin—testicular cancer	0.000176	0.000787	CcSEcCtD
Eprosartan—Hypotension—Methotrexate—testicular cancer	0.000176	0.000785	CcSEcCtD
Eprosartan—Loss of consciousness—Doxorubicin—testicular cancer	0.000176	0.000783	CcSEcCtD
Eprosartan—Cough—Doxorubicin—testicular cancer	0.000174	0.000778	CcSEcCtD
Eprosartan—Shock—Epirubicin—testicular cancer	0.000173	0.000773	CcSEcCtD
Eprosartan—Thrombocytopenia—Epirubicin—testicular cancer	0.000172	0.00077	CcSEcCtD
Eprosartan—Tachycardia—Epirubicin—testicular cancer	0.000172	0.000767	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000171	0.000765	CcSEcCtD
Eprosartan—Hyperhidrosis—Epirubicin—testicular cancer	0.00017	0.00076	CcSEcCtD
Eprosartan—Insomnia—Methotrexate—testicular cancer	0.00017	0.00076	CcSEcCtD
Eprosartan—Myalgia—Doxorubicin—testicular cancer	0.00017	0.000759	CcSEcCtD
Eprosartan—Chest pain—Doxorubicin—testicular cancer	0.00017	0.000759	CcSEcCtD
Eprosartan—Arthralgia—Doxorubicin—testicular cancer	0.00017	0.000759	CcSEcCtD
Eprosartan—Anxiety—Doxorubicin—testicular cancer	0.000169	0.000756	CcSEcCtD
Eprosartan—Paraesthesia—Methotrexate—testicular cancer	0.000169	0.000754	CcSEcCtD
Eprosartan—Discomfort—Doxorubicin—testicular cancer	0.000168	0.00075	CcSEcCtD
Eprosartan—Anorexia—Epirubicin—testicular cancer	0.000168	0.000749	CcSEcCtD
Eprosartan—Dyspnoea—Methotrexate—testicular cancer	0.000168	0.000749	CcSEcCtD
Eprosartan—Somnolence—Methotrexate—testicular cancer	0.000167	0.000747	CcSEcCtD
Eprosartan—Dry mouth—Doxorubicin—testicular cancer	0.000166	0.000742	CcSEcCtD
Eprosartan—Dyspepsia—Methotrexate—testicular cancer	0.000166	0.000739	CcSEcCtD
Eprosartan—Hypotension—Epirubicin—testicular cancer	0.000165	0.000734	CcSEcCtD
Eprosartan—Decreased appetite—Methotrexate—testicular cancer	0.000164	0.00073	CcSEcCtD
Eprosartan—Fatigue—Methotrexate—testicular cancer	0.000162	0.000724	CcSEcCtD
Eprosartan—Pain—Methotrexate—testicular cancer	0.000161	0.000718	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.00016	0.000716	CcSEcCtD
Eprosartan—Shock—Doxorubicin—testicular cancer	0.00016	0.000716	CcSEcCtD
Eprosartan—Thrombocytopenia—Doxorubicin—testicular cancer	0.00016	0.000712	CcSEcCtD
Eprosartan—Insomnia—Epirubicin—testicular cancer	0.000159	0.000711	CcSEcCtD
Eprosartan—Tachycardia—Doxorubicin—testicular cancer	0.000159	0.00071	CcSEcCtD
Eprosartan—Paraesthesia—Epirubicin—testicular cancer	0.000158	0.000706	CcSEcCtD
Eprosartan—Hyperhidrosis—Doxorubicin—testicular cancer	0.000158	0.000703	CcSEcCtD
Eprosartan—Dyspnoea—Epirubicin—testicular cancer	0.000157	0.000701	CcSEcCtD
Eprosartan—Somnolence—Epirubicin—testicular cancer	0.000157	0.000699	CcSEcCtD
Eprosartan—Anorexia—Doxorubicin—testicular cancer	0.000155	0.000693	CcSEcCtD
Eprosartan—Feeling abnormal—Methotrexate—testicular cancer	0.000155	0.000692	CcSEcCtD
Eprosartan—Dyspepsia—Epirubicin—testicular cancer	0.000155	0.000692	CcSEcCtD
Eprosartan—Gastrointestinal pain—Methotrexate—testicular cancer	0.000154	0.000687	CcSEcCtD
Eprosartan—Decreased appetite—Epirubicin—testicular cancer	0.000153	0.000683	CcSEcCtD
Eprosartan—Hypotension—Doxorubicin—testicular cancer	0.000152	0.00068	CcSEcCtD
Eprosartan—Fatigue—Epirubicin—testicular cancer	0.000152	0.000678	CcSEcCtD
Eprosartan—Constipation—Epirubicin—testicular cancer	0.000151	0.000672	CcSEcCtD
Eprosartan—Pain—Epirubicin—testicular cancer	0.000151	0.000672	CcSEcCtD
Eprosartan—Urticaria—Methotrexate—testicular cancer	0.00015	0.000667	CcSEcCtD
Eprosartan—Body temperature increased—Methotrexate—testicular cancer	0.000149	0.000664	CcSEcCtD
Eprosartan—Abdominal pain—Methotrexate—testicular cancer	0.000149	0.000664	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000148	0.000663	CcSEcCtD
Eprosartan—Insomnia—Doxorubicin—testicular cancer	0.000147	0.000658	CcSEcCtD
Eprosartan—Paraesthesia—Doxorubicin—testicular cancer	0.000146	0.000653	CcSEcCtD
Eprosartan—Dyspnoea—Doxorubicin—testicular cancer	0.000145	0.000648	CcSEcCtD
Eprosartan—Feeling abnormal—Epirubicin—testicular cancer	0.000145	0.000648	CcSEcCtD
Eprosartan—Somnolence—Doxorubicin—testicular cancer	0.000145	0.000647	CcSEcCtD
Eprosartan—Gastrointestinal pain—Epirubicin—testicular cancer	0.000144	0.000643	CcSEcCtD
Eprosartan—Dyspepsia—Doxorubicin—testicular cancer	0.000143	0.00064	CcSEcCtD
Eprosartan—Decreased appetite—Doxorubicin—testicular cancer	0.000142	0.000632	CcSEcCtD
Eprosartan—Fatigue—Doxorubicin—testicular cancer	0.000141	0.000627	CcSEcCtD
Eprosartan—Urticaria—Epirubicin—testicular cancer	0.00014	0.000624	CcSEcCtD
Eprosartan—Constipation—Doxorubicin—testicular cancer	0.000139	0.000622	CcSEcCtD
Eprosartan—Pain—Doxorubicin—testicular cancer	0.000139	0.000622	CcSEcCtD
Eprosartan—Body temperature increased—Epirubicin—testicular cancer	0.000139	0.000621	CcSEcCtD
Eprosartan—Abdominal pain—Epirubicin—testicular cancer	0.000139	0.000621	CcSEcCtD
Eprosartan—Hypersensitivity—Methotrexate—testicular cancer	0.000139	0.000619	CcSEcCtD
Eprosartan—Asthenia—Methotrexate—testicular cancer	0.000135	0.000603	CcSEcCtD
Eprosartan—Feeling abnormal—Doxorubicin—testicular cancer	0.000134	0.000599	CcSEcCtD
Eprosartan—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000133	0.000595	CcSEcCtD
Eprosartan—Pruritus—Methotrexate—testicular cancer	0.000133	0.000594	CcSEcCtD
Eprosartan—Hypersensitivity—Epirubicin—testicular cancer	0.00013	0.000579	CcSEcCtD
Eprosartan—Urticaria—Doxorubicin—testicular cancer	0.000129	0.000578	CcSEcCtD
Eprosartan—Abdominal pain—Doxorubicin—testicular cancer	0.000129	0.000575	CcSEcCtD
Eprosartan—Body temperature increased—Doxorubicin—testicular cancer	0.000129	0.000575	CcSEcCtD
Eprosartan—Diarrhoea—Methotrexate—testicular cancer	0.000129	0.000575	CcSEcCtD
Eprosartan—Asthenia—Epirubicin—testicular cancer	0.000126	0.000564	CcSEcCtD
Eprosartan—Pruritus—Epirubicin—testicular cancer	0.000125	0.000556	CcSEcCtD
Eprosartan—Dizziness—Methotrexate—testicular cancer	0.000124	0.000555	CcSEcCtD
Eprosartan—Diarrhoea—Epirubicin—testicular cancer	0.000121	0.000538	CcSEcCtD
Eprosartan—Hypersensitivity—Doxorubicin—testicular cancer	0.00012	0.000536	CcSEcCtD
Eprosartan—Vomiting—Methotrexate—testicular cancer	0.00012	0.000534	CcSEcCtD
Eprosartan—Rash—Methotrexate—testicular cancer	0.000119	0.00053	CcSEcCtD
Eprosartan—Dermatitis—Methotrexate—testicular cancer	0.000119	0.000529	CcSEcCtD
Eprosartan—Headache—Methotrexate—testicular cancer	0.000118	0.000526	CcSEcCtD
Eprosartan—Asthenia—Doxorubicin—testicular cancer	0.000117	0.000522	CcSEcCtD
Eprosartan—Dizziness—Epirubicin—testicular cancer	0.000116	0.00052	CcSEcCtD
Eprosartan—Pruritus—Doxorubicin—testicular cancer	0.000115	0.000515	CcSEcCtD
Eprosartan—Vomiting—Epirubicin—testicular cancer	0.000112	0.0005	CcSEcCtD
Eprosartan—Nausea—Methotrexate—testicular cancer	0.000112	0.000499	CcSEcCtD
Eprosartan—Diarrhoea—Doxorubicin—testicular cancer	0.000112	0.000498	CcSEcCtD
Eprosartan—Rash—Epirubicin—testicular cancer	0.000111	0.000496	CcSEcCtD
Eprosartan—Dermatitis—Epirubicin—testicular cancer	0.000111	0.000495	CcSEcCtD
Eprosartan—Headache—Epirubicin—testicular cancer	0.00011	0.000492	CcSEcCtD
Eprosartan—Dizziness—Doxorubicin—testicular cancer	0.000108	0.000481	CcSEcCtD
Eprosartan—Nausea—Epirubicin—testicular cancer	0.000105	0.000467	CcSEcCtD
Eprosartan—Vomiting—Doxorubicin—testicular cancer	0.000104	0.000462	CcSEcCtD
Eprosartan—Rash—Doxorubicin—testicular cancer	0.000103	0.000459	CcSEcCtD
Eprosartan—Dermatitis—Doxorubicin—testicular cancer	0.000103	0.000458	CcSEcCtD
Eprosartan—Headache—Doxorubicin—testicular cancer	0.000102	0.000456	CcSEcCtD
Eprosartan—Nausea—Doxorubicin—testicular cancer	9.68e-05	0.000432	CcSEcCtD
